Evidence map›Paper›PMID 34070698›Full record

ArticleJournal of clinical medicine2021

Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study.

Federico Pessina, Pierina Navarria, Elena Clerici, Luisa Bellu, Andrea Franzini, Davide Milani, Matteo Simonelli, Pasquale Persico, Letterio S Politi, Alessandra Casarotti and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. A comparison study of dynamic [Journal of cancer research and clinical oncology · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Federico PessinaNeurosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Pierina NavarriaRadiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.ORCID 0000-0002-6913-1442
Elena ClericiRadiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Luisa BelluRadiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.ORCID 0000-0002-7286-4014
Andrea FranziniNeurosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Davide MilaniNeurosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Matteo SimonelliDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy.ORCID 0000-0002-5264-1251
Pasquale PersicoOncology and Hematology Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.ORCID 0000-0003-2446-8604
Letterio S PolitiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy.ORCID 0000-0002-6190-6688
Alessandra CasarottiNeurosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Bethania FernandesPathology Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.ORCID 0000-0002-4327-1586
Simone OleiNeurosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Martina SolliniDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy.
Arturo ChitiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy.
Marta ScorsettiNeurosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
IRCCS Humanitas Research Hospital · ITHumanitas University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: We investigated the role of [11C]-methionine PET in a cohort of newly diagnosed glioblastoma multiforme (GBM) patients to evaluate whether it could modify the extent of surgical resection and improve radiation therapy volume delineation. (2) Methods: Newly diagnosed GBM patients, ages 18-70, with a Karnofsky performance scale (KPS) ≥ 70 with available MRI and [11C]-methionine PET were included. Patients were treated with different amounts of surgical resection followed by radio-chemotherapy. The role of [11C]-methionine PET in surgical and RT planning was analyzed. A threshold of SUVmax was searched. (3) Results: From August 2013 to April 2016, 93 patients were treated and included in this analysis. Residual tumor volume was detected in 63 cases on MRI and in 78 on [11C]-methionine PET, including 15 receiving gross total resection. The location of uptake was mainly observed in FLAIR abnormalities. [11C]-methionine uptake changed RT volume in 11% of patients. The presence of [11C]-methionine uptake in patients receiving GTR proved to influence survival (

Indexed as

[11C]-methionine PETnewly diagnosed glioblastomaradiation therapysupratotal resectionsurgery

Identifiers

PMID34070698
PMCPMC8198980
OpenAlexW3165318231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.